medroxyprogesterone acetate has been researched along with Leukocytopenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H | 1 |
| Gondo, H; Nakajima, Y; Sato, N; Sato, Y; Uchino, J; Une, Y | 1 |
| Pedrazzoli, P | 1 |
| Mani, S; Poo, WJ | 1 |
1 review(s) available for medroxyprogesterone acetate and Leukocytopenia
| Article | Year |
|---|---|
Single institution experience with recombinant gamma-interferon in the treatment of patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Cohort Studies; Disease Progression; Fatigue; Female; Fever; Humans; Injections, Intravenous; Interferon-gamma; Kidney Neoplasms; Leukopenia; Male; Medroxyprogesterone Acetate; Middle Aged; Nausea; Recombinant Proteins; Remission Induction; Survival Rate; Vomiting | 1996 |
3 trial(s) available for medroxyprogesterone acetate and Leukocytopenia
| Article | Year |
|---|---|
Chemohormonal therapy of unresectable hepatocellular carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Diseases; Leukopenia; Liver Diseases; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1993 |
Single institution experience with recombinant gamma-interferon in the treatment of patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Cohort Studies; Disease Progression; Fatigue; Female; Fever; Humans; Injections, Intravenous; Interferon-gamma; Kidney Neoplasms; Leukopenia; Male; Medroxyprogesterone Acetate; Middle Aged; Nausea; Recombinant Proteins; Remission Induction; Survival Rate; Vomiting | 1996 |
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors | 1986 |
2 other study(ies) available for medroxyprogesterone acetate and Leukocytopenia
| Article | Year |
|---|---|
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged | 2005 |
Myeloprotective effect of medroxyprogesterone acetate (MPA)
Topics: Cell Count; Hematopoietic Stem Cells; Humans; Leukopenia; Medroxyprogesterone Acetate; Thrombocytopenia | 1993 |